MAPT and Alzheimer disease: In conclusion, C3G could alleviate AD pathology by improving cognitive functioning, clearing Aβ plaques, reducing inflammation and enhancing antioxidation, attenuating tau protein phosphorylation and neuronal apoptosis, and enhancing autophagy and neuronal plasticity.